Showing results (81-90 of 131) with videos related to

Sort By:
Pageof 14
Experimental Neurology|August 30, 2008
Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: an in vivo 11C-raclopride PET studyMarios Politis, Paola Piccini, Nicola Pavese, et al.
International Review of Neurobiology|January 15, 2019
Hybrid PET-MRI Applications in Movement DisordersGiacomo Tondo, Marcello Esposito, George Dervenoulas, et al.
Neuroimage. Clinical|May 31, 2018
Serotonergic dysregulation is linked to sleep problems in Parkinson's diseaseHeather Wilson, Beniamino Giordano, Federico E Turkheimer, et al.
Human Brain Mapping|September 15, 2019
Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairmentAvinash Chandra, Polytimi-Eleni Valkimadi, Gennaro Pagano, et al.
Neurology|August 10, 2018
REM behavior disorder predicts motor progression and cognitive decline in Parkinson diseaseGennaro Pagano, Rosa De Micco, Tayyabah Yousaf, et al.
Neurology|April 19, 2013
Serotonergic loss in motor circuitries correlates with severity of action-postural tremor in PDClare Loane, Kit Wu, Peter Bain, et al.
Vaccines|May 26, 2026
Measles Seroprevalence Among Healthcare Workers in a Tertiary Hospital in Central Greece, 2017Eirini Karnava, Marios Politis, Efthymia Petinaki, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 15, 2010
Parkinson's disease symptoms: the patient's perspectiveMarios Politis, Kit Wu, Sophie Molloy, et al.
Neurobiology of Aging|October 17, 2020
Aquaporin-4 polymorphisms predict amyloid burden and clinical outcome in the Alzheimer's disease spectrumAvinash Chandra, Chloe Farrell, Heather Wilson, et al.
Neurobiology of Disease|July 3, 2010
Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET studyMarios Politis, Kit Wu, Clare Loane, et al.
Pageof 14